Dr. Vinod Balachandran, who received the Yvonne Award 2024, was named to The Washington Post’s Next 50
Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“Congratulations to Dr. Vinod Balachandran, a surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering Cancer Center (MSK), for being named to the inaugural edition of The Washington Post’s Next 50, a list of up-and-coming changemakers shaping society in 2025.
Dr. Balachandran was selected for his groundbreaking work to advance personalized messenger RNA (mRNA) vaccines for the treatment of pancreatic cancer.
‘This recognition highlights the incredible dedication and relentless effort of my lab members and collaborators at MSK,’ says Dr. Balachandran. ‘Their passion and commitment are what drives progress towards new therapies for pancreatic and other deadly cancers.’
Learn more about Dr. Balachandran’s breakthrough work and how MSK is at the leading edge of a new generation of immune-based treatments.”
More posts featuring Memorial Sloan Kettering Cancer Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023